delete PART 870—CARDIOVASCULAR DEVICES
This regulation establishes the classification framework for cardiovascular devices, determining which require premarket approval and which have exemptions. It defines class III devices requiring FDA approval, class II devices with special controls, and class I devices with exemptions, while providing procedures for substantial equivalence determination and grandfathering provisions for devices in commercial distribution before 1976.
This regulatory framework creates excessive barriers to medical innovation, increases healthcare costs through compliance burdens, and protects established manufacturers from competition. The FDA's premarket approval process delays life-saving devices from reaching patients, while the substantial equivalence standard prevents truly innovative designs from entering the market. Medical device safety is better achieved through market competition, professional liability, and voluntary certification rather than federal micromanagement.